Hospital General Universitario de Valencia; Servicio de oncologia

Valencia 46014

0 studies enrolling now · 4 studies all time

What they study most

Advanced BRAFV600 Wild-type Melanoma, Basal Cell Carcinoma, Bladder Cancer, Triple Negative Breast Cancer

Studies at this site

• A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer — Stopped early
• A Study of Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Participants With Previously Untreated Advanced BRAFv600 Wild-Type Melanoma — Stopped early
• A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211] — Completed
• A Study of Two Vismodegib Regimens in Participants With Multiple Basal Cell Carcinomas — Completed